| Sana Quddus, MD | |
|
2160 S 1st Ave, Fahey Building 130, Maywood, IL 60153-3328 | |
| (708) 216-9000 | |
| Not Available |
| Full Name | Sana Quddus |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 23 Years |
| Location | 2160 S 1st Ave, Maywood, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275744724 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loyola University Medical Center | Maywood, IL | Hospital |
| Elmhurst Memorial Hospital | Elmhurst, IL | Hospital |
| Central Dupage Hospital | Winfield, IL | Hospital |
| Gottlieb Memorial Hospital | Melrose park, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loyola University Medical Center | 3779488903 | 863 |
News Archive
iWorx, a developer of advanced physiology research tools, has introduced the IX-100BE Data Acquisition System with LabScribe2 Software that provides high resolution/low noise recording of biopotential signals for OEM applications.
Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been released and are now available for shipment.
Advocates for obesity prevention and treatment have designed two new resources for medical educators, healthcare providers and community programs that will enhance the level of care for patients, according to two new studies published online today in Obesity, the flagship journal of The Obesity Society.
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
› Verified 2 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
iWorx, a developer of advanced physiology research tools, has introduced the IX-100BE Data Acquisition System with LabScribe2 Software that provides high resolution/low noise recording of biopotential signals for OEM applications.
Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been released and are now available for shipment.
Advocates for obesity prevention and treatment have designed two new resources for medical educators, healthcare providers and community programs that will enhance the level of care for patients, according to two new studies published online today in Obesity, the flagship journal of The Obesity Society.
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sana Quddus, MD 2160 S 1st Ave, Fahey Building 130, Maywood, IL 60153-3328 Ph: (708) 216-9000 | Sana Quddus, MD 2160 S 1st Ave, Fahey Building 130, Maywood, IL 60153-3328 Ph: (708) 216-9000 |
News Archive
iWorx, a developer of advanced physiology research tools, has introduced the IX-100BE Data Acquisition System with LabScribe2 Software that provides high resolution/low noise recording of biopotential signals for OEM applications.
Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been released and are now available for shipment.
Advocates for obesity prevention and treatment have designed two new resources for medical educators, healthcare providers and community programs that will enhance the level of care for patients, according to two new studies published online today in Obesity, the flagship journal of The Obesity Society.
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
› Verified 2 days ago
Dr. Cathryn T Sawalski, DO, MBA Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Suhana Elamsenthil, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Holly Kramer, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2160 S First Ave, 101-1740 Loyola University Medical Center, Maywood, IL 60153 Phone: 708-216-9000 Fax: 708-216-9033 | |
Dr. Stephanie Bochen Tsai, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Nicholas Poellinger, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Sofia Ahmed, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-8757 | |
Shelly Lo, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Luh - North Ent., Rm. 7604, Maywood, IL 60153 Phone: 708-216-3304 Fax: 708-216-1259 |